Encoded Therapeutics Inc.

📍 South San Francisco, United States🗓 Founded 2014👥 182 employees💰 Last funded May 2019
Biotechnology Research🌐 Encoded.com
Website LinkedIn
Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. The Encoded approach offers potentially unprecedented gene specificity and cell selectivity to unlock novel opportunities by targeting a range of disease mechanisms. Encoded’s technology is compatible with any delivery system to control where and when therapeutic transgenes are expressed, thereby shaping the functionality of target cells and holding broader therapeutic potential beyond CNS disorders. For more information, please visit www.encoded.com, and follow us on LinkedIn, Twitter @EncodedTx and YouTube. Social media guidelines: https://encoded.com/social-media-community-guidelines/
4
Total investors
1
Early stage
3
Mid stage
0
Late stage
2014
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2015–2019 · investors recorded per year
201512017120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Encoded Therapeutics Inc.?
Encoded Therapeutics Inc. has 4 investors on record on gritt.io, including 1 early-stage backers, 3 mid-stage.
When did Encoded Therapeutics Inc. last raise funding?
The most recent investment in Encoded Therapeutics Inc. recorded on gritt.io was in May 2019.
When was Encoded Therapeutics Inc. founded?
Encoded Therapeutics Inc. was founded in 2014.
What industry is Encoded Therapeutics Inc. in?
Encoded Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Encoded Therapeutics Inc. based?
Encoded Therapeutics Inc. is headquartered in South San Francisco, United States.